Liver Cirrhosis, Experimental
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Influence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration.
|
12586293 |
2003 |
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
Influence of leptin in the development of hepatic fibrosis produced in mice by Schistosoma mansoni infection and by chronic carbon tetrachloride administration.
|
12586293 |
2003 |
Liver Cirrhosis, Experimental
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats.
|
15772939 |
2005 |
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
Ribozymes against TGFbeta1 reverse character of activated hepatic stellate cells in vitro and inhibit liver fibrosis in rats.
|
15772939 |
2005 |
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
RGD |
[Effects of salvianolic acid B on expressions of TGF-beta1 and its receptors in liver of rats with dimethylnitrosamine-induced hepatic fibrosis].
|
16009107 |
2005 |
Liver Cirrhosis, Experimental
|
0.500 |
Therapeutic
|
disease |
CTD_human |
The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis.
|
16579972 |
2006 |
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis.
|
16579972 |
2006 |
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
Role of NLRC5 in progression and reversal of hepatic fibrosis.
|
26806094 |
2016 |
Liver Cirrhosis, Experimental
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Role of NLRC5 in progression and reversal of hepatic fibrosis.
|
26806094 |
2016 |
Liver Cirrhosis, Experimental
|
0.500 |
Biomarker
|
disease |
CTD_human |
Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues.
|
27605418 |
2016 |
Liver Cirrhosis, Experimental
|
0.500 |
Therapeutic
|
disease |
CTD_human |
Editor's Highlight: Modeling Compound-Induced Fibrogenesis In Vitro Using Three-Dimensional Bioprinted Human Liver Tissues.
|
27605418 |
2016 |
Liver Cirrhosis, Experimental
|
0.500 |
Therapeutic
|
disease |
RGD |
Heat shock protein 47 as indispensible participant in liver fibrosis: Possible protective effect of lactoferrin.
|
30092114 |
2018 |
Liver Cirrhosis, Experimental
|
0.500 |
ModifyingMutation
|
disease |
RGD |
Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc.
|
30243650 |
2018 |